Companies
AtaiBeckley completes Lilly merger with $6.75 cash payment and contingent rights
AtaiBeckley is now a wholly owned Lilly subsidiary. Shareholders receive cash plus a right to milestone payments of up to $2.50, while the company has requested Nasdaq delisting.
